CS
TSVT

Credit Suisse’s 2seventy bio TSVT Stock Holding History

Credit Suisse’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,243,449
Closed -$4.87M – 3152
2023
Q3 		$4.87M Buy
1,243,449
+222,496
+22% +$1.46M 0.01% 1284
2023
Q2 		$10.3M Buy
1,020,953
+2,979
+0.3% +$31.5K 0.01% 909
2023
Q1 		$10.4M Buy
1,017,974
+11,231
+1% +$128K 0.01% 924
2022
Q4 		$9.43M Buy
1,006,743
+993
+0.1% +$14K 0.01% 960
2022
Q3 		$14.6M Sell
1,005,750
-612
-0.1% -$9.08K 0.02% 762
2022
Q2 		$13.3M Buy
1,006,362
+1,990
+0.2% +$27.1K 0.01% 829
2022
Q1 		$17.1M Buy
1,004,372
+170,888
+21% +$2.9M 0.01% 828
2021
Q4 		$21.4M Buy
+833,484
New +$26M 0.01% 1062

Other funds holding TSVT

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
ECM
Engine Capital Management New York $828M AUM 6.49% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Credit Suisse's TSVT Position: Q4 2023 in Review

Credit Suisse sold out of 2seventy bio (TSVT) in Q4 2023, closing a stake of 1,243,449 shares — an estimated $4.87M sold.

Credit Suisse first reported a position in TSVT in Q4 2021 and held it in 8 quarters. The position peaked at $21.4M in Q4 2021. 116 funds tracked by Wall St. Rank hold TSVT as of Q4 2023.

  • Credit Suisse reported no remaining 2seventy bio position as of Q4 2023 after selling out during the quarter.
  • Credit Suisse sold 1,243,449 2seventy bio shares in Q4 2023, an estimated $4.87M.
  • Credit Suisse first reported a position in 2seventy bio in Q4 2021 and held it in 8 quarters.
  • Credit Suisse's 2seventy bio position peaked at $21.4M in Q4 2021.
  • 116 funds tracked by Wall St. Rank held 2seventy bio as of Q4 2023.

Based on Credit Suisse's 13F filing for Q4 2023, filed 8 Feb 2024.